TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers at the University Hospital of Bonn and the University of Bonn directly reprogrammed human red blood cell precursors into neural stem cells in laboratory experiments. The cells’ epigenetic clocks shifted toward a younger profile, including in cells from an 80-year-old donor, but the work does not show that a person’s body has been rejuvenated or that the method treats disease.
Researchers at the University Hospital of Bonn and the University of Bonn have directly converted human red blood cell precursors into neural stem cells in laboratory experiments, while tracking a gradual shift in the cells’ epigenetic age markers. In cells from an 80-year-old person, the researchers reported a molecular-age reading of less than 20 years after reprogramming; the result is a finding about cells in a test tube, not evidence that aging has been reversed in a person.
The team used transcription factors—proteins that influence which genetic instructions a cell reads—to change the developmental identity of blood-cell precursors. The cells were converted directly into neural stem cells, which can give rise to nerve cells, rather than first being taken through a pluripotent stem-cell stage. The study, by Berg and colleagues, was published in the journal Aging Cell.
To follow changes associated with age, researchers measured DNA modifications used in epigenetic clocks. These modifications affect how genes are read but do not alter the underlying DNA sequence. The report says the clocks were reset substantially during conversion and that the shift unfolded over more than 100 days. It also describes an example in which cells from an 80-year-old donor showed a molecular age below 20 years.
The investigators say the cells’ behavior was consistent with a younger state, but the evidence described concerns cells grown and tested in the laboratory. It does not establish that all features of aging were reversed, that the effect would occur in a living person, or that the resulting cells are ready for medical use.
A Slower Route to Study Cell Aging
The reported process may give researchers a way to observe cellular reprogramming over time, rather than only comparing cells before and after a rapid conversion. The Bonn team says that because the epigenetic-clock changes developed over weeks, the method could help investigate which factors speed up or slow down the shift. That could make it useful as a laboratory model for studying how cell identity and age-associated molecular patterns change together.
The work is also relevant to neuroscience research because the converted cells are neural stem cells, and age is a major risk factor for neurodegenerative conditions such as Alzheimer’s disease. However, the study does not report a treatment for Alzheimer’s or any other condition. It describes a research approach that could support future investigations, not a demonstrated clinical benefit.
That distinction matters for readers: a younger reading on an epigenetic clock is a measurement of particular molecular features, not a direct measure of a person’s overall health, lifespan, or brain function. The potential value lies in what researchers may learn from the model, not in an available anti-aging intervention.
As an affiliate, we earn on qualifying purchases.
Direct Conversion Avoids a Stem-Cell Stage
Cells in the body share genetic material but acquire different roles as they develop. In laboratory reprogramming, researchers use transcription factors to change which genes a cell activates, allowing it to take on a different identity. Earlier approaches to producing neural stem cells from blood cells commonly involved an intermediate pluripotent stem-cell stage, which can develop into many cell types.
The Bonn researchers say their method instead converted blood-cell precursors directly into neural stem cells. The report contrasts this with two-stage reprogramming, in which a blood cell is first made pluripotent and then guided toward a neural fate. Rejuvenation had previously been observed during reprogramming, according to the report, but the direct method allowed the team to follow the changes gradually over an extended period.
The researchers also cite prior work in which nerve cells produced through related methods formed connections with existing neurons after transplantation into mouse brains. That earlier result provides research context, but it does not show that the current cells were tested as a treatment or that such an approach is safe or effective in people.
“We have directly converted red blood cell precursors into neural stem cells.”
— Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at University Hospital of Bonn
As an affiliate, we earn on qualifying purchases.
What the Cell-Age Reading Shows
The report does not provide enough detail to establish how broadly the result applies across donors, cell samples, or laboratories. It also does not specify here how the reported molecular-age estimates relate to other measures of cell function, or whether the clock shift persists over the long term after conversion. Those questions require further research.
Most importantly, the work was performed on cells in a test tube. The report does not show that the technique rejuvenates tissues or organs in a person, improves health, extends life, or treats neurodegenerative disease. Nor does it establish that the converted cells are safe for transplantation in humans. An epigenetic-clock estimate describes selected molecular patterns; it should not be read as a literal statement that a cell, or its donor, has become a particular number of years younger.
cell reprogramming laboratory tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing Factors Behind the Slow Reset
The research team says the gradual clock shift could be used to investigate which factors and active substances accelerate or slow cellular rejuvenation during direct conversion. The next scientific questions include how the process unfolds, how stable the resulting neural stem cells are, and whether changes in epigenetic clocks correspond to durable changes in cell function.
The study itself does not announce a clinical trial or a timetable for medical use. Further laboratory work would be needed before researchers could determine whether the method has any therapeutic application. The published findings appear in Aging Cell as “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells” (DOI: 10.1111/acel.70751).
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the Bonn researchers do?
They used transcription factors to directly convert human red blood cell precursors into neural stem cells in laboratory experiments, without first passing through a pluripotent stem-cell stage.
What does it mean that the cells appeared younger?
The researchers measured DNA modifications used by epigenetic clocks and reported that the readings shifted toward a younger molecular profile. This is a measurement of selected cell markers, not proof that a person’s body has become younger.
Were the cells from an 80-year-old donor?
The report says cells from an 80-year-old showed a molecular-age reading of less than 20 years after reprogramming. The finding concerns those cells in the laboratory and should not be interpreted as changing the donor’s age or health.
Could this method treat Alzheimer’s disease?
The study does not show that the method treats or prevents Alzheimer’s disease. The researchers describe it as a model that may help investigate cell rejuvenation, with potential relevance to neuroscience research.
What happens next?
The researchers say the extended process could help them test what speeds up or slows down the epigenetic changes. More research is needed to assess the mechanism, durability, cell function, safety, and any possible clinical application.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
